微波消融治疗原发性肝癌的现状
Current Situation of Microwave Ablation for Primary Liver Cancer
DOI: 10.12677/ACM.2020.106170, PDF,   
作者: 陈 聪, 郑 寒：延安大学，陕西 延安；刘勇峰*：延安大学附属医院，陕西 延安
关键词: 微波消融；肝癌；术后并发症；Microwave Ablation； Liver Cancer； Postoperative Complications
摘要: 原发性肝癌是我国常见的恶性肿瘤之一，其中肝细胞癌(Hepatocellular Carcinoma)约占90%，肝癌的发病率与死亡率均高，是全球导致死亡的第二大癌症，而我国有接近全球一半的肝癌病例。随着科技的发展，目前临床上肝癌的治疗方式主要包括外科手术治疗，介入治疗，消融治疗，免疫治疗等，其中微波消融治疗在临床应用日渐增多，因其具有延长患者的生存时间，减少并发症，术后恢复快的优势。本文主要论述微波消融在肝癌中的应用，希望能为临床医治肝癌提供科学合理的建议。
Abstract: Primary carcinoma of liver is one of the most common malignant tumors in China, of which hepatocellular Carcinoma (Hepatocellular Carcinoma) accounts for about 90%, china has nearly half of the world’s liver cancer cases. With the development of science and technology, the current clinical treatment of liver cancer mainly includes surgical treatment, interventional treatment, ablation treatment, immunotherapy and so on, of which Microwave Ablation has the advantages of prolonging survival time, reducing the complications and recovering quickly after operation. This article mainly discusses the application of Microwave Ablation in liver cancer, hoping to provide scientific and reasonable suggestions for clinical treatment of liver cancer.
文章引用：陈聪, 郑寒, 刘勇峰. 微波消融治疗原发性肝癌的现状[J]. 临床医学进展, 2020, 10(6): 1121-1126. https://doi.org/10.12677/ACM.2020.106170

参考文献

[1] 朱笑生, 刘文超. 原发性肝癌全球流行情况和危险因素的新进展[J]. 现代肿瘤医学, 2018, 26(14): 2297-2301.
[2] 顾贤波, 任利. 热消融技术在治疗肝癌中的应用[J]. 世界最新医学信息文摘, 2019, 19(30): 82-83.
[3] 金鹏, 孙钢. 肝癌消融治疗的研究进展[J]. 中华消化病与影像杂志(电子版), 2016, 6(3): 97-102.
[4] 王亦秋, 饶建华, 刘鹏, 等. 射频消融或微波消融分别联合肝动脉化疗栓塞治疗原发性肝癌的效果比较[J]. 中国临床研究, 2017, 30(11): 1441-1445.
[5] 熊翔, 陈斌. 小肝癌切除术与微波消融术的临床疗效对比[J]. 中国实用医药, 2017, 12(16): 80-82.
[6] 孔凡豹, 刘婷. 小肝癌微波消融术后疗效的CT及MRI随访对照研究[J]. 肝脏, 2018, 23(2): 157-159.
[7] Glassberg, M.B., Ghosh, S., Clymer, J.W., et al. (2019) Microwave Ablation Compared with Hepatic Resection for the Treatment of Hepatocellular Carcinoma and Liver Metastases: A Systematic Review and Meta-Analysis. World Journal of Surgical Oncology, 17, 98. [Google Scholar] [CrossRef] [PubMed]
[8] 马智, 杨帆. 微波消融术与肝段切除术治疗原发性小肝癌的近期疗效及远期预后对比分析[J]. 解放军医药杂志, 2017, 29(12): 32-35.
[9] Fang, L., Meng, X., Luo, W., et al. (2019) Treatment of Primary Hepatic Carcinoma through Ultrasound-Guided Microwave Ablation. Nigerian Journal of Clinical Practice, 22, 1408-1411. [Google Scholar] [CrossRef] [PubMed]
[10] 周传力, 张珍, 徐亚吉, 等. 经皮微波消融与手术切除治疗原发性小肝癌疗效Meta分析[J]. 四川生理科学杂志, 2019, 41(2): 103-107.
[11] Tan, W., Deng, Q., Lin, S., et al. (2019) Comparison of Microwave Ablation and Radiofrequency Ablation for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. International Journal of Hyperthermia, 36, 264-272. [Google Scholar] [CrossRef] [PubMed]
[12] 王新亭, 张传雷, 陈晓琦, 等. 经皮射频消融与微波消融治疗BCLC-A期肝癌的疗效对比[J]. 肝脏, 2018, 23(8): 683-685.
[13] 杨晓燕, 周传力. 射频与微波消融治疗肝脏肿瘤的效果对比[J]. 影像研究与医学应用, 2018, 2(12): 114-115.
[14] Liu, W., Zheng, Y., He, W., et al. (2018) Microwave vs Radiofrequency Ablation for Hepatocellular Carcinoma within the Milan Criteria: A Propensity Score Analysis. Alimentary Pharmacology & Therapeutics, 48, 671-681. [Google Scholar] [CrossRef] [PubMed]
[15] 赵金艳, 张一军, 刘学. 微波消融与射频消融对≤5 cm单发小肝癌疗效的分析比较[J]. 中华肿瘤防治杂志, 2018, 25(S2): 76-77.
[16] Santambrogio, R., Chiang, J., Barabino, M., et al. (2017) Comparison of Laparoscopic Microwave to Radiofrequency Ablation of Small Hepatocellular Carcinoma (≤3 cm). Annals of Surgical Oncology, 24, 257-263. [Google Scholar] [CrossRef] [PubMed]
[17] Thornton, L.M., Cabrera, R., Kapp, M., et al. (2017) Radiofrequency vs Microwave Ablation after Neoadjuvant Transarterial Bland and Drug-Eluting Microsphere Chembolization for the Treatment of Hepatocellular Carcinoma. Current Problems in Diagnostic Radiology, 46, 402-409. [Google Scholar] [CrossRef] [PubMed]
[18] 刘健. 原发性肝癌直接微波消融的临床效果探究[J]. 世界最新医学信息文摘, 2016, 16(3): 163-164.
[19] 孙厚坦, 赵威武, 杨峰, 等. 中晚期肝癌的联合治疗进展[J]. 现代中西医结合杂志, 2012, 21(33): 3756-3758.
[20] 张慧贤, 马向明. 经肝动脉化疗栓塞联合经皮微波消融序贯治疗中晚期肝癌的疗效及预后分析[J]. 肝脏, 2017, 22(5): 431-434.
[21] 官明. 肝动脉栓塞化疗联合经皮微波消融对中晚期肝癌的疗效[J]. 肝脏, 2016, 21(12): 1054-1056.
[22] 陆阳, 赵卫, 李星海, 等. TACE联合阿帕替尼或微波消融治疗中晚期肝细胞癌现状[J]. 中国介入影像与治疗学, 2018, 15(7): 443-446.
[23] 陈刚, 唐晓军, 魏强, 等. 超声造影评价肝动脉化疗栓塞联合微波消融治疗中晚期肝癌疗效[J]. 东南国防医药, 2016, 18(5): 531-533, 539.
[24] Smolock, A.R., Cristescu, M.M., Hinshaw, A., et al. (2018) Combination Transarterial Chemoembolization and Microwave Ablation Improves Local Tumor Control for 3- to 5-cm Hepatocellular Carcinoma When Compared with Transarterial Chemoembolization Alone. Abdominal Radiology, 43, 2497-2504. [Google Scholar] [CrossRef] [PubMed]
[25] Zhang, R., Shen, L., Zhao, L., et al. (2018) Combined Transarterial Chemoembolization and Microwave Ablation versus Transarterial Chemoembolization in Bclc Stage B Hepatocellular Carcinoma. Diagnostic and Interventional Radiology, 24, 219-224. [Google Scholar] [CrossRef] [PubMed]
[26] 谢仁辉, 彭平亚, 宁俊华. 加味柴胡清肝饮联合微波消融术治疗中晚期肝癌临床研究[J]. 中医临床研究, 2017, 9(10): 23-25.
[27] 郭争捷, 林建军, 金昌男, 等. 艾迪联合超声引导微波凝固治疗原发性肝癌临床观察[J]. 中医药通报, 2006, 5(6): 51-54.
[28] 赵亚杰. 经腹腔镜引导微波固化术对特殊部位肝癌的临床意义[D]: [硕士学位论文]. 武汉: 华中科技大学, 2016.
[29] Asvadi, N.H., Anvari, A., Uppot, R.N., et al. (2016) CT-Guided Percutaneous Microwave Ablation of Tumors in the Hepatic Dome: Assessment of Efficacy and Safety. Journal of Vascular and Interventional Radiology, 27, 496-502. [Google Scholar] [CrossRef] [PubMed]
[30] 陈建, 金霞, 陈晓, 等. 人工腹水对膈面脏面原发性肝癌微波消融治疗中的应用价值[J]. 实用临床医药杂志, 2019, 23(6): 7-12.
[31] 王俊东, 魏达友, 吴绍锋, 等. 超声新技术辅助特殊部位小肝癌微波消融与手术切除的疗效对比研究[J]. 中国超声医学杂志, 2019, 35(6): 506-510.
[32] 于锋, 万文博. 超声引导下微波消融术联合TACE治疗特殊部位中晚期原发性肝癌的疗效及安全性分析[J]. 临床超声医学杂志, 2019, 21(6): 479-480.
[33] Liu, A., Xu, W., Xu, H., et al. (2017) Therapeutic Effect of Transcatheter Arterial Chemoembolization Combined with Ultrasound-Guided Microwave Ablation for Treatment of Liver Cancer in Special Sites. Chinese Journal of Hepatology, 25, 914-919.
[34] 韩海云, 经翔, 丁建民, 等. 经皮微波消融治疗危险部位肝癌的安全性和疗效分析[J]. 中国介入影像与治疗学, 2017, 14(4): 205-209.
[35] Filippiadis, D.K., Spiliopoulos, S., Konstantos, C., et al. (2018) Computed Tomography-Guided Percutaneous Microwave Ablation of Hepatocellular Carcinoma in Challenging Locations: Safety and Efficacy of High-Power Microwave Platforms. International Journal of Hyperthermia, 34, 863-869. [Google Scholar] [CrossRef] [PubMed]
[36] 王延明, 周平盛, 钱国军. 肝癌微创消融治疗相关并发症研究进展[J]. 人民军医, 2019, 62(5): 455-460.
[37] 李因茵, 于燕波, 刘泽, 等. 328例原发性肝癌单点及多点微波消融术后并发症的观察与分析[J]. 中华保健医学杂志, 2018, 20(6): 464-466.
[38] Hoffmann, R., Rempp, H., Keßler, D.E., et al. (2017) MR-Guided Microwave Ablation in Hepatic Tumours: Initial Results in Clinical Routine. European Radiology, 27, 1467-1476. [Google Scholar] [CrossRef] [PubMed]
[39] Ma, S., Ding, M., Li, J., et al. (2017) Ultrasound-Guided Percutaneous Microwave Ablation for Hepatocellular Carcinoma: Clinical Outcomes and Prognostic Factors. Journal of Cancer Research and Clinical Oncology, 143, 131-142. [Google Scholar] [CrossRef] [PubMed]
[40] Yin, T., Li, W., Zhao, P., et al. (2017) Treatment Efficacy of CT-Guided Percutaneous Microwave Ablation for Primary Hepatocellular Carcinoma. Clinical Radiology, 72, 136-140. [Google Scholar] [CrossRef] [PubMed]
[41] Zhang, H., Hou, X., Cai, H., et al. (2017) Effects of Microwave Ablation on T-Cell Subsets and Cytokines of Patients with Hepatocellular Carcinoma. Minimally Invasive Therapy & Allied Technologies, 26, 207-211. [Google Scholar] [CrossRef] [PubMed]
[42] 马思聪, 王涛, 丁敏, 等. 超声引导下微波消融一线治疗原发性肝癌: 临床疗效以及预后影响因素[J]. 肝脏, 2016, 21(5): 355-359.
[43] Facciorusso, A., Di maso, M. and Muscatiello, N. (2016) Microwave Ablation versus Radiofrequency Ablation for the Treatment of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. International Journal of Hyperthermia, 32, 339-344. [Google Scholar] [CrossRef] [PubMed]

为你推荐